DRMA:NASDAQ, Dermata Therapeutics, Inc.

DRMA stock overview

Dermata Therapeutics, Inc. (DRMA:NASDAQ) closed at $0.599 on November 16, 2026, down 3.65% on the day. The stock trades 87.2% below its 52-week high of $4.66 and 5.7% above its 52-week low of $0.566. Over the past year, it lost 77.6%. Dermata Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.599
Day change
-3.65%
Volume
48,756
Average volume
2,792,995
Market cap
2M+
52-week range
$0.566 – $4.66
50-day average
$0.967
200-day average
$1.23

Price action over the past year

In 252 trading sessions since November 14, 2025, DRMA closed higher on 101 days (40%). Its best day was February 19, 2026 (+50.78%) and its worst was February 20, 2026 (-30.05%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

DRMA news

About Dermata Therapeutics, Inc.

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.

Similar stocks

Find more stocks like DRMA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.